|
π
|
Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR
44 auth.
S. Ghorashian,
A. Kramer,
S. Onuoha,
Gary Wright,
J. Bartram,
R. Richardson,
Sarah J. Albon,
Joan Casanovas-Company,
Fernanda V. V. Castro,
B. Popova,
K. Villanueva,
Jenny Yeung,
Winston Vetharoy,
A. Guvenel,
P. Wawrzyniecka,
...
L. Mekkaoui,
G. Cheung,
Danielle Pinner,
J. Chu,
G. Lucchini,
Juliana M. F. Silva,
O. CiocΓ’rlie,
A. Lazareva,
S. Inglott,
K. Gilmour,
G. Ahsan,
M. Ferrari,
Somayya Manzoor,
K. Champion,
T. Brooks,
A. Lopes,
A. Hackshaw,
F. Farzaneh,
R. Chiesa,
K. Rao,
D. Bonney,
S. Samarasinghe,
N. Goulden,
A. Vora,
P. Veys,
R. Hough,
R. Wynn,
M. Pule,
P. Amrolia
|
8 |
2019 |
8
π
|
|
π
|
Chimeric Antigen Receptor-Engineered Human Gamma Delta T Cells: Enhanced Cytotoxicity with Retention of Cross Presentation
12 auth.
A. Capsomidis,
Gabriel Benthall,
H. Van Acker,
J. Fisher,
A. Kramer,
Z. Abeln,
...
Y. Majani,
Talia Gileadi,
Rebecca Wallace,
K. Gustafsson,
B. Flutter,
John Anderson
|
7 |
2017 |
7
π
|
|
π
|
Expansion of myeloid derived suppressor cells correlates with number of T regulatory cells and disease progression in myelodysplastic syndrome
12 auth.
A. Kittang,
S. Kordasti,
Kristoffer Sand,
B. Costantini,
A. Kramer,
Pilar Perezabellan,
...
T. Seidl,
K. P. Rye,
K. Hagen,
A. Kulasekararaj,
Γ. Bruserud,
G. Mufti
|
6 |
2015 |
6
π
|
|
π
|
E. coli promotes human VΞ³9VΞ΄2βT cell transition from cytokine-producing bactericidal effectors to professional phagocytic killers in a TCR-dependent manner
8 auth.
M. Barisa,
A. Kramer,
Y. Majani,
Dale Moulding,
Luisa Saraiva,
Mona Bajaj-Elliott,
...
John Anderson,
Kenth Gustafsson
|
4 |
2017 |
4
π
|
|
π
|
Sensitivity and resistance towards isoliquiritigenin, doxorubicin and methotrexate in T cell acute lymphoblastic leukaemia cell lines by pharmacogenomics
8 auth.
M. Youns,
Yu-jie Fu,
Y. Zu,
A. Kramer,
V. B. Konkimalla,
B. Radlwimmer,
...
H. SΓΌltmann,
T. Efferth
|
4 |
2010 |
4
π
|
|
π¬
|
Non-V delta 2 gamma delta T lymphocytes as effectors of cancer immunotherapy
J. Fisher,
A. Kramer,
K. Gustafsson,
John Anderson
|
3 |
2014 |
3
π¬
|
|
π
|
A Novel Low Affinity CD19CAR Results in Durable Disease Remissions and Prolonged CAR T Cell Persistence without Severe CRS or Neurotoxicity in Patients with Paediatric ALL
29 auth.
S. Ghorashian,
A. Kramer,
Sarah J. Albon,
Gary Wright,
Fernanda V. V. Castro,
B. Popova,
Catherine Irving,
Winston Vetharoy,
R. Richardson,
Danielle Pinner,
J. Chu,
G. Lucchini,
Juliana M. F. Silva,
O. CiocΓ’rlie,
S. Inglott,
...
K. Champion,
A. Hackshaw,
F. Farzaneh,
R. Chiesa,
K. Rao,
A. Rao,
P. Ancliffe,
S. Samarasinghe,
A. Vora,
P. Veys,
R. Hough,
R. Wynn,
M. Pule,
P. Amrolia
|
3 |
2017 |
3
π
|
|
π¬
|
[The role of the dog in the epidemiology of neosporosis in cattle].
W. Wouda,
T. Dijkstra,
A. Kramer,
C. Bartels
|
2 |
2000 |
2
π¬
|
|
π¦
|
Construction and Pre-Clinical Evaluation of a New Anti-CD19 Chimeric Antigen Receptor
9 auth.
A. Kramer,
S. Ghorashian,
G. Cheung,
Winston Vetharoy,
D. Moulding,
L. Mekkaoui,
...
S. Onuoha,
P. Amrolia,
M. Pule
|
2 |
2016 |
2
π¦
|
